DCM
GILD icon

DGS Capital Management’s Gilead Sciences GILD Stock Holding History

DGS Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Buy
14,029
+1,253
+10% +$175K 0.32% 58
2025
Q4 		$1.57M Buy
12,776
+1,499
+13% +$182K 0.27% 68
2025
Q3 		$1.25M Buy
11,277
+1,653
+17% +$188K 0.23% 80
2025
Q2 		$1.07M Buy
9,624
+3,371
+54% +$359K 0.22% 84
2025
Q1 		$701K Buy
6,253
+2,981
+91% +$308K 0.18% 114
2024
Q4 		$302K Sell
3,272
-302
-8% -$27.2K 0.08% 218
2024
Q3 		$300K Sell
3,574
-1,492
-29% -$114K 0.08% 217
2024
Q2 		$348K Sell
5,066
-3,743
-42% -$250K 0.1% 189
2024
Q1 		$645K Buy
8,809
+1,021
+13% +$78.5K 0.18% 108
2023
Q4 		$631K Buy
7,788
+122
+2% +$9.49K 0.24% 82
2023
Q3 		$574K Buy
7,666
+934
+14% +$71.8K 0.28% 80
2023
Q2 		$519K Buy
6,732
+162
+2% +$12.9K 0.26% 85
2023
Q1 		$545K Buy
6,570
+131
+2% +$10.8K 0.3% 74
2022
Q4 		$553K Sell
6,439
-144
-2% -$11.4K 0.36% 60
2022
Q3 		$406K Buy
6,583
+1,619
+33% +$102K 0.27% 75
2022
Q2 		$307K Buy
+4,964
New +$307K 0.25% 102

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

DGS Capital Management's GILD Position: Q1 2026 in Review

DGS Capital Management increased its Gilead Sciences (GILD) stake by 9.8% in Q1 2026, buying an estimated $175K and bringing the position to 14,029 shares worth $1.96M. The position accounts for 0.32% of the portfolio, ranked #58.

DGS Capital Management first reported a position in GILD in Q2 2022 and has held it in 16 quarters since. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • DGS Capital Management held 14,029 shares of Gilead Sciences worth $1.96M as of Q1 2026.
  • DGS Capital Management bought 1,253 Gilead Sciences shares in Q1 2026, an estimated $175K.
  • Gilead Sciences made up 0.32% of DGS Capital Management's portfolio in Q1 2026, its #58 holding.
  • DGS Capital Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 16 quarters since.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.